Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316433 · ClinicalTrials.gov registry record · Phase 2
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
A Phase 2 study, sponsored by Swedish Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00316433: Clinical Trial Phase 2 study, sponsored by Swedish Medical Center.
NCT00316433 is a Phase 2 study that was terminated before completion, run by Swedish Medical Center. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00316433, a Phase 2 study, was terminated before completion, sponsored by Swedish Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.
Interventions
- DRUG Irinotecan (CPT-11)
- DRUG Oxaliplatin (Eloxatin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-01 |
| Phase | Phase 2 |
Why NCT00316433 stopped before completion
NCT00316433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Irinotecan (CPT-11) is the first listed.
NCT00316433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00316433 about?
NCT00316433 is a clinical study titled "Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer". The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.
What is the current status of trial NCT00316433?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2005-02. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00316433?
The interventions under investigation include: Irinotecan (CPT-11) (DRUG), Oxaliplatin (Eloxatin) (DRUG).
Who is sponsoring clinical trial NCT00316433?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00316433's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia